Aethlon Medical, Inc. (NASDAQ:AEMD) short interest fell 20.1% in September

Aethlon Medical, Inc. (NASDAQ:AEMD – Get Free Report ) was the target of a significant drop in short interest in September. As of September 15th, there was short interest totaling 182,100 shares, down 20.1% from its August 31st total of 227,800 shares. Based on an average daily volume of 2,000,000 shares, the days-to-cover ratio is currently 0.1 days.

Analysts set new price targets

Several analysts have recently issued reports on the stock. HC Wainwright cut their price target on shares of Aethlon Medical from $10.00 to $7.00 and set a “buy” rating on the stock in a research report on Monday, June 24th. StockNews.com assumed coverage on shares of Aethlon Medical in a research report on Saturday, September 21st. They set a “sell” rating on the stock.

Read our latest analysis on AEMD

Aethlon medical stock performance

Shares of AEMD stock opened at $0.48 on Friday. The company’s 50-day moving average price is $0.39 and its 200-day moving average price is $0.79. Aethlon Medical has a fifty-two week low of $0.24 and a fifty-two week high of $2.40. The firm has a market cap of $6.63 million, a price-to-earnings ratio of -0.09 and a beta of 1.72.

Aethlon Medical (NASDAQ:AEMD – Get Your Free Report ) last posted its earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.44) by $0.10. In the same quarter last year, the business earned ($1.30) EPS. Stock analysts forecast that Aethlon Medical will register -1.1 EPS for the current fiscal year.

About Aethlon Medical

(Get a free report)

Aethlon Medical, Inc, a therapeutic medical company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. She is developing the Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses for use in organ transplantation.

Featured stories

Get news and reviews for Aethlon Medical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aethlon Medical and related companies with MarketBeat.com’s FREE daily email newsletter.